Isotretinoin and pregnancy termination: an overview
Int J Dermatol
.
2023 Apr;62(4):e255-e256.
doi: 10.1111/ijd.16570.
Epub 2022 Dec 29.
Authors
Ayman Abdelmaksoud
1
2
,
Uwe Wollina
3
,
Torello Lotti
4
5
,
Selami A Temiz
6
Affiliations
1
Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
2
Department of Dermatology, University of Studies Guglielmo Marconi, Rome, Italy.
3
Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany.
4
University of Rome G. Marconi, Rome, Italy.
5
Department of Dermatology and Communicable Diseases, First Medical State Moscow University I. M. Sechenev, Moscow, Russia.
6
Department of Dermatology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
PMID:
36582022
DOI:
10.1111/ijd.16570
No abstract available
Publication types
Letter
Review
Comment
MeSH terms
Abortion, Induced*
Acne Vulgaris* / drug therapy
Dermatologic Agents* / adverse effects
Female
Humans
Isotretinoin / adverse effects
Pregnancy
Substances
Dermatologic Agents
Isotretinoin